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Genetically-encoded sensors to detect fatty acid
production and trafﬁcking
Emilio P. Mottillo 1, *, 2, Huamei Zhang 1, Alexander Yang 1, Li Zhou 1, James G. Granneman 1
ABSTRACT
Objective: Fatty acids are important for biological function; however, in excess, they can cause metabolic dysregulation. Methods to image and
detect fatty acids in real time are lacking. Therefore, the current study examined the dynamics of fatty acid trafﬁcking and signaling utilizing novel
ﬂuorescent and luminescent approaches.
Methods: We generated ﬂuorescent and luminescent-based genetically-encoded sensors based upon the ligand-dependent interaction between
PPARa and SRC-1 to image and detect cellular dynamics of fatty acid trafﬁcking.
Results: The use of a ﬂuorescent sensor demonstrates that fatty acids trafﬁc rapidly from lipid droplets to the nucleus. Both major lipases ATGL
and HSL contribute to fatty acid signaling from lipid droplet to nucleus, however, their dynamics differ. Furthermore, direct activation of lipolysis,
independent of receptor-mediated signaling is sufﬁcient to promote lipid droplet to nuclear trafﬁcking of fatty acids. A luminescent-based sensor
that reports intracellular fatty acid levels is amenable to high-throughput analysis.
Conclusions: Fatty acids trafﬁc from lipid droplets to the nucleus within minutes of stimulated lipolysis. Genetically-encoded ﬂuorescent and
luminescent based sensors can be used to probe the dynamics of fatty acid trafﬁcking and signaling.
Ó 2019 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. INTRODUCTION
Fatty acids (FAs) are a signiﬁcant energy source and substrates for
membrane synthesis that are required for cellular growth and division.
Importantly, recent work has identiﬁed a role for FAs as signaling
molecules in regulating lipid homeostasis [1]. On the other hand,
excessive levels of FAs can lead to a build up of toxic lipid metabolic
intermediates in a process termed lipotoxicity [2]. This buildup of lipids
can have negative effects that are causative in various metabolic
disorders, such as diabetes [3] and cardiovascular disease [4]. However, our understanding of FA metabolism has been hampered by the
lack of methods to detect their production in a temporal and spatial
manner in live cells.
FAs are stored safely in the form of triacylglycerol (TAG) within lipid
droplet (LD) organelles [5]. During times of energy demand these
stores are mobilized by lipases on the surface of LDs. In adipocytes,
this process is mediated by the major lipases adipose triglyceride
lipase (ATGL; also known as Patatin Like Phospholipase Domain
Containing 2, PNPLA2), the rate limiting enzyme for TAG hydrolysis and
hormone sensitive lipase (HSL), a major diacylglycerol (DAG) lipase [6].
In brown adipocytes (BAs), FAs are essential regulators of thermogenesis [7,8] by supplying energy for mitochondrial electron transport
and functioning as allosteric activators of uncoupling protein 1 (UCP1)

[9], the molecular mechanisms for brown adipose tissue non-shivering
thermogenesis.
Recent work has demonstrated that ATGL and HSL can regulate the
transcription of various genes involved in FA metabolism and uncoupling such as peroxisome proliferator-activated receptor gamma
coactivator 1-alpha (PGC1a), pyruvate dehydrogenase kinase 4
(PDK4), and UCP1, likely by providing ligands for nuclear transcription
factors peroxisome proliferator-activated receptors (PPARs) [10e13].
However, the temporal and spatial regulation of how FAs might trafﬁc
to promote gene expression is not known. In addition, methods to
detect real time mobilization of intracellular FAs are lacking. Here we
describe the development of genetically-encoded sensors based upon
the ligand-dependent interaction between PPARa and steroid receptor
coactivator-1 (SRC-1) to image the production and trafﬁcking of FAs by
ﬂuorescent and luminescent means.
2. METHODS AND EXPERIMENTAL PROCEDURES
2.1. cDNA cloning and generation of cell lines
Cloning for the PPARa ligand binding domain (LBD) and the SRC-1
fragment were previously described [10]. Brieﬂy, the bipartite FA
sensor was generated by ﬁrst cloning the LXXLL domain of SRC-1
(amino acids, aa; 620e770) on the C-terminus of EYFP (Clontech).
The LBD of human PPARa (aa 191e467) was cloned on the C-
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Abbreviations
ABHD5
Ai
ATGL
BA
BAY
BSA
DAG
Dox
FA
Gluc
HSL
HTS

Alpha-beta hydrolase domain-containing 5
Atglistatin
Adipose triglyceride lipase
Brown adipocyte
BAY 59-9435
Bovine serum albumin
Diacylglycerol
Doxycycline
Fatty acid
Gaussia luciferase
hormone sensitive lipase
High-throughput screening

terminus of full-length Perilipin-1 (PLIN1). The PLIN1- PPARa LBD
fusion was then sub-cloned on the C-terminus of EYFP-SRC1 separated by a P2A sequence.
The cDNA for a monomeric luciferase FA sensor was commercially
synthesized (Genewiz Inc.). Brieﬂy, Gaussia luciferase (Gluc) was split
into optimized N-terminal (aa 18e105; GlucN) and C-terminal fragments (aa 106e185; GlucC) as previous described [14]. The GlucN
fragment was followed by the LBD of PPARa, the LXXLL motif of SRC-1
and ﬁnally the GlucC fragment. Each fragment was separated by
ﬂexible linkers 2X(Gly-Gly-Gly-Gly-Ser). The synthesized DNA fragment
containing AgeI and XbaI sites was cloned into the same sites of ECFPC1.
The indicated constructs were cloned into the lentivirus vector (pINDUCER20) as previously described [15,16]. For lentiviral packaging,
pINDUCER20 target plasmid was co-transfected with pMD2.G and
psPAX2 packaging vectors into HEK293T cells using lipofectamine LTX
and plus reagent (Invitrogen). 48 h and 72 h post transfection, viruscontaining culture media was harvested and passed through 0.45 mM
ﬁlters to remove debris. To collect the virus, the media was centrifuged
at 48,000 g for 2 h 4  C in a Beckman 25.50 ﬁxed angle rotor, and the
virus pellet was resuspended in OPTIMEM. Stable brown adipocyte (BA)
cells line expressing sensors were generated by infecting with virus for
24 h followed by G418 selection (800 mg/ml) for one week.
2.2. Cell culture
HEK293T and COS-7 cells were purchased from ATCC. Mouse brown
preadipocyte cells lines were generated in the labs of Dr. Bruce
Spiegelman (Harvard University) or Dr. Gregory Steinberg (McMaster
University) and were provided as gifts. All cells were maintained in
DMEM High Glucose (Hyclone GE Lifesciences) with 10% FCS (Atlanta
Biologicals) and Penicillin/Streptomycin (Hyclone, GE Lifesciences).
Brown preadipocytes were differentiated by treating cells with induction medium (20 nM insulin, 1 nM T3, 0.5 mM isobutylmethylxanthine,
0.5 mM dexamethasone, and 0.125 mM indomethacin) for 48 h, followed by maintenance in differentiation media (20 nM insulin, 1 nM T3)
until complete differentiation at 7 days. The expression of stably integrated sensors was induced by treating cells with 1 mg/ml doxycycline for 24e48 h.
2.3. Microscopy
Images were acquired using an Olympus IX-81 microscope equipped
with a spinning-disc confocal unit. Microscope control and data
acquisition were performed using CellSens Dimensions (Olympus)
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software. BAs grown and differentiated on 35 mm glass coverslips
were imaged in HEPES-Krebs-Ringer buffer (Sigma) supplemented
with 1% BSA (Alkali Scientiﬁc). EYFP ﬂuorescent images were acquired
using a 40  (0.9 NA) or 60  (1.2 NA) water immersion lens. EYFP
reporter images were acquired every minute, with basal ﬂuorescence
recorded for the ﬁrst 3e5 min, followed by stimulation of lipolysis
(forskolin/IBMX, 2 mM and 200 mM; ABHD5 ligand; isoproterenol). The
region of interest (ROI; lipid droplets, nucleus or cytoplasm) for each
frame was quantiﬁed using ImageJ software (NIH) and the LD or nucleus ROI was normalized to cytoplasm to correct for any nonspeciﬁc
changes in ﬂuorescent intensity due to minor changes in excitation or
focal plane. Data were then expressed as a fold of basal ﬂuorescence.
2.4. Immunoﬂuorescence
BAs grown on 35 mm glass coverslips were induced to express the
ﬂuorescent FA sensor for 48 h. Cells were treated with vehicle or
Isoproterenol for 20 min as above for microscopy experiments. Fixed
cells were permeabilized with phosphate-buffered saline containing
5% normal donkey serum and 0.01% saponin (Permeabilization buffer)
for 15 min, then incubated for 50 min in Permeabilization buffer with
primary antibody against PLIN1 (goat, 1:200, Everest Biotech, Cat#
EB07728). The slides were washed four times, 5 min each, with
phosphate-buffered saline, then incubated for 1 h with Alexa Fluor 555
conjugated donkey anti-goat (1:1000; Invitrogen) in Permeabilization
buffer. The slides were washed again, then counterstained for nuclei
(40 ,6-diamidino-2-phenylindole; 1:5000) in phosphate-buffered saline.
Slides were ﬁnally washed with phosphate-buffered saline and imaged
as above on an Olympus IX-81.
2.5. Gene expression analysis
RNA was isolated from BAs using a Nucleospin RNA II kit (MacheryNagel) as indicated by the manufacturer. Total RNA was reverse
transcribed using Superscript III (Invitrogen) with oligo(dT) primers
(ThermoFisher). Fifty nanograms of cDNA was analyzed in a 20-ml
quantitative PCR reaction (ABsolute Blue QPCR SYBR; ThermoScientiﬁc) with 80 nM of primers. Expression data were normalized to
the housekeeping gene peptidylprolyl cisetrans isomerase A (PPIA)
using the DDCT method (2DDCT) [17]. cDNAs were ampliﬁed using
primers as previously described [10].
2.6. Luciferase assays
Immediately following treatments, cells were washed once with PBS
and luciferase assays were performed by lysing cells in Gluc assay
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buffer (30 mM Tris pH 8.0, 300 mM NaCl, 0.1% Tween 20) [18] for
20 min at room temperature with gentle rotation. Luciferase activity
was measured by injecting coelenterazine (20 mM) in PBS and
measuring luminescence over a 2 s integration.
2.7. Biochemical measurements
Fatty acids released in the media were determined using a WAKO NEFA
HR kit (Wako Pure Chemicals Industries) adapted to ﬂuorescence
detection with Amplex Red (Cayman Chemical). Glycerol was quantiﬁed using the Free Glycerol (Sigma) reagent with colorimetric
determination.
3. RESULTS
3.1. Fluorescent imaging reveals dynamic trafﬁcking of fatty acids
from lipid droplets to nucleus
We previously described a ﬂuorescent method to monitor the production of PPARa and PPARd ligands on LDs [10]. This assay involves
targeting the ligand binding domain (LBD) of PPARa to the LD surface
by fusing it to Perilipin 1 (PLIN1) and tagging the LxxLL motif of SRC-1
with EYFP. The presence of a FA (i.e., PPAR ligand) promotes the ligand
dependent interaction between PPARa and SRC-1, which can be
monitored by the accumulation of ﬂuorescence at the LD surface. In

addition to monitoring ligand production to genetically-targeted PPARa
LBD, translocation of tagged SRC1 to endogenous nuclear receptors
could provide a means of monitoring FA-induced transactivation in real
time. To improve on the original design [10], we incorporated the
targeted LBD and ﬂuorescent co-activator reporter into a single transcript using the P2A peptide to control relative expression levels.
Furthermore, we put the construct under the control of a doxycycline
inducible promoter (Figure 1A) and created a stable BA cell line that
allowed controlled expression to detect the ligand dependent interaction (Figure 1B). In BA cells treated with doxycycline, EYFP-SRC-1
ﬂuorescence was localized throughout the cytosol with some nuclear
localization. Upon activation of protein kinase A (PKA) with forskolin/
IBMX to stimulate lipolysis, ﬂuorescent EYFP-SRC1 rapidly translocated
to the LD surface (arrowheads; Figure 1C,D, Supplementary Movie 1),
indicating that PPARa ligands (i.e. fatty acids) are immediately produced from LDs upon stimulation of lipolysis. Quantiﬁcation of regions
of interest (ROI) demonstrated a robust increase in EYFP ﬂuorescence
on the LD that occurred within 1e3 min of stimulating lipolysis. This
early burst in the accumulation of EYFP was followed by a steady
continuous accumulation in signal (Figure 1E). Somewhat unexpectedly, we also observed accumulation of EYFP-SRC1 within the nucleus
(black arrows). The accumulation of EYFP-SRC1 in the nucleus steadily
increased over 15 min and lacked the rapid phase observed at the LD

Figure 1: Design of a ﬂuorescent sensor to detect fatty acid trafﬁcking on lipid droplets and in the nucleus. (A) Schematic for the design of a doxycycline (Dox) inducible
bipartite ﬂuorescent sensor to detect fatty acids. The co-activation domain of SRC1 is tagged to EYFP (EYFP-SRC1), separated by a P2A self-cleaving site with PLIN1-PPARa fusion,
which targets the ligand binding domain of PPARa to lipid droplets. Dox binds reverse tetracycline-controlled transactivator (rtTA3), which promotes binding to the TRE2 promoter
to induce expression of the fatty acid sensor. (B) In the presence of ligand (fatty acid; FFA), EYFP-SRC1 binds to PLIN1-PPARa on the surface of LDs. EYFP-SRC1 can also
translocate to endogenous nuclear receptors that are sensitive to fatty acids. Stable expression of the ﬂuorescent fatty acid reporter in brown adipocytes under basal conditions (C)
and protein kinase A (PKA) stimulation (Stim; forskolin/IBMX) for 20 min (D). Arrows note accumulation of EYFP-SRC1 on lipid droplets while arrowheads note accumulation within
the nucleus following stimulation. Quantiﬁcation of the region of interest on lipid droplet (E) and nucleus (F) normalized to the cytosol signal and expressed as fold of basal.
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surface (Figure 1F). We conﬁrmed using immunoﬂuorescence that the
PLIN1-PPARa fusion remains on LD during stimulation (Supplementary
Figure 1). Thus, the translocation of EYFP-SRC1 to the nucleus most
likely represents the FA-dependent interaction of EYFP-SRC1 with
endogenous nuclear receptors (Supplementary Figure 1). These data
demonstrate the rapid mobilization of FAs on LDs and their detection in
the nucleus.
Supplementary video related to this article can be found at https://doi.
org/10.1016/j.molmet.2019.08.012
ATGL and HSL are the major adipocyte lipases which differ in their
targeted substrates and mode of activation [6,19]. In the basal state
ATGL has weak TAG lipase activity; however, PKA activation phosphorylates PLIN1 to release the co-activator alpha-beta hydrolase
domain-containing 5 (ABHD5, also known as CGI-58) [20], which then
activates ATGL [19]. In contrast, HSL is directly phosphorylated by PKA,
which targets the lipase to LD surfaces and increases its activity
[21,22]. Both ATGL and HSL contribute to adipocyte lipolysis, acting as
selective TAG and DAG lipases, respectively, yet how these lipases
contribute the temporal and spatial mobilization of FAs has not been

investigated. As shown in Figure 2A, activation of b-adrenergic receptors with isoproterenol (Iso) triggered a burst of EYFP-SRC1 ﬂuorescence on LD surfaces within 2 min of activation, followed by a
steady increase over the next 15 min. Pharmacological inhibition of
HSL with BAY 59e9435 (BAY) [23] eliminated the rapid rise in ﬂuorescence associated with LDs, but left largely intact the slower rise
observed in control cells. Conversely, the rapid phase of FA mobilization was intact in the presence of ATGL inhibition with Atglistatin (Ai)
[24], yet enduring mobilization of FAs was largely eliminated in the
absence of ATGL activity (Figure 2A). These observations indicate that
HSL can mediate a very rapid mobilization of FAs, and that ATGL is
critical for sustained mobilization. Furthermore, results indicate that
both lipases function in concert to achieve a full lipolytic response,
consistent with experiments that monitor extracellular accumulation of
FAs (Supplementary Figure 2).
Fluorescent-tagged SRC-1 accumulation in the nucleus showed
somewhat different kinetics, with no detectible burst and a slow
accumulation that was similarly sensitive to inhibition of ATGL or HSL
(Figure 2B). Consistent with the notion that ATGL and HSL are the

Figure 2: Role of ATGL, HSL and ABHD5 in fatty acid trafﬁcking from lipid droplets and in the nucleus. Individual contribution of ATGL and HSL to fatty acid signaling on lipid
droplets (A) and in the nucleus (B). Combined contribution of both ATGL and HSL to fatty acid signaling on lipid droplets (C) and in the nucleus (D). Cell were pretreated with DMSO
(in the case for Iso alone) or in the presence of ATGL inhibitor (Ai, 10 mM), HSL inhibitor (BAY, 5 mM), or both inhibitors for 20 min, then imaged basally for three minutes, followed
by stimulation with isoproterenol (Iso, 1 mM) for 15 min. Role of direct ABHD5 activation on fatty acid signaling on lipid droplets (E) and in the nucleus (F). Brown adipocytes were
imaged basally for 3 min followed by stimulation with Isoproterenol (Iso, 1 mM) or ABHD5 activation (SR-3420, 20 mM) for 15 min. The region of interest on lipid droplet, nucleus
was quantiﬁed and normalized to the cytosol signal and expressed as fold of basal.
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major adipocyte lipases, dual inhibition of ATGL and HSL completely
blocked the accumulation of EYFP-SRC1 (Figure 2C) on LDs and
reduced accumulation in the nucleus by greater than 80% (Figure 2D).
These data demonstrate that FAs can trafﬁc from the LD to the nucleus
through the function of ATGL and HSL and that these enzymes differ in
their kinetics of FA mobilization on LDs.
The results with lipase inhibition indicate that PKA-induced HSL activation mediates rapid FA mobilization, whereas the sustained phase of
LD-mediated FA signaling requires ATGL that might be independent of
transmembrane signaling. To address the role of PKA activation in the
temporal control of lipolysis, we compared receptor mediatedactivation by Iso with that induced by ABHD5 ligands, which activate
ATGL-dependent lipolysis directly [15,25]. These ligands stimulate
lipolysis by binding ABHD5, reducing its afﬁnity for PLIN1, thereby
stimulating ATGL-dependent lipolysis independently of PKA. As expected, Iso promoted the increase in EYFP-SRC1 with two distinct
phases, while direct activation of ABHD5 with SR-3420 promoted the
steady accumulation of EYFP-SRC1 on the LD surface that lacked the
initial burst observed with receptor activation (Figure 2E). Interestingly,
the proﬁle of EYFP-SRC1 accumulation on LDs triggered by SR-3420
mimicked that of receptor mediated lipolysis when it was driven
exclusively by ATGL (Figure 2A, BAY/Iso). The accumulation of EYFPSRC1 within the nucleus was similar whether lipolysis was induced
via activation of b-adrenergic receptors with isoproterenol or triggered
by activation of ABHD5 with SR-3420 (Figure 2F). Overall, these results
demonstrate that direct activation of lipolysis is sufﬁcient to promote
FA trafﬁcking from LDs to the nucleus.
The accumulation of EYFP-SRC1 within the nucleus suggested that
FAs might trafﬁc to the nucleus to modulate gene transcription via
endogenous nuclear receptors. Because the fragment of SRC-1 used

as a reporter lacks the activation domain, we reasoned that binding
of this reporter to endogenous transcription factors might function as
a dominant-negative to suppress the transcription of genes
responsive to FA production. As shown in Figure 3A, Iso increased
the expression of known PPAR target genes that are involved in fatty
acid oxidation (PGC1a, PPARa, PDK4) and UCP1. Furthermore,
doxycycline-induced expression of EYFP-SRC1 (þDox) lowered the
expression of these genes but not expression of NOR-1 [10], a direct
PKA target gene. (Figure 3A). Importantly, the expression of the SRC1 fragment did not affect the release of FAs (Supplementary
Figure 3). Overall, these results indicate a LD to nucleus pathway
that communicates the metabolic status of the cell to rapidly regulate
the expression of genes involved in fatty acid oxidation and
uncoupling.
3.2. A high throughput luciferase-based sensor to detect
intracellular fatty acids
The ﬂuorescent reporter provides local information on FA signaling. We
next sought to determine whether the sensor system described could
be adapted for high-throughput screening (HTS). To do so, we engineered luciferase complementation based on optimized fragments for
a split Gaussia luciferase (Gluc) [26] into a single genetically-encoded
reporter (Figure 4A). In HEK 293T cells transiently transfected with the
luciferase sensor, the addition of PPAR ligands resulted in an increase
in luciferase signal in response to PPARa ligands Wy14-643 (Wy) and
GW7647, but not PPARg ligand rosiglitazone (Figure 4B). A dose
response for Wy resulted in a calculated EC50 of 0.54 mM, similar to the
reported EC50 values for this ligand (Figure 4C) [27,28]. Overall, these
results demonstrate that the luminescent based sensor is selectively
responsive to PPARa ligands.

Figure 3: The dominant-negative fragment of SRC-1 suppresses the induction of known PPAR target genes. Brown adipocyte cells stably expressing the SRC-1 fragment in
a doxycycline-inducible manner were treated with (þDox) or without (-Dox) doxycycline (1 mg/ml) for 48 h, followed by vehicle (Ctl) or Isoproterenol (Iso, 10 mM) for four hours. The
RNA was extracted, and the expression of the indicated genes was measured. *p < 0.05 and ***p < 0.001 indicate a signiﬁcant effect of doxycycline-induced expression of EYFPSRC-1 on the expression of genes induced by isoproterenol treatment (Iso) as determine by two-way ANOVA with Bonferroni post t-test. n.s. indicates a non-signiﬁcant effect.
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Figure 4: Design of a monomeric luminescent sensor to detect fatty acids. (A) Schematic for the design of monomeric luciferase sensor to detect fatty acids. The N-terminal
fragment of gaussia luciferase (Gluc) was fused in tandem with the ligand binding domain of PPARa, the LxxLL motif of SRC-1 and the C-terminal domain of Gluc. Fragments were
separated by glycine/serine ﬂexible regions. (B) Brown pre-adipocytes stably expressing the Gluc fatty acid sensor were treated with the indicated PPAR ligands (Wy 14e643,
100 mM (Wy); GW7647, 1 mM; Rosiglitazone, 1 mM (Rosi)) and the Relative Luminescence Units (RLUs) were determined and expressed as a fold of DMSO. Data are from three
independent experiments performed in triplicate. ***p < 0.001 indicates a signiﬁcant effect compared to DMSO as determined by one-way ANOVA. (C) Dose response for the
PPARa ligand Wy in 293T cells transfected with the Gluc fatty acid sensor. Data are from one experiment performed in quadruplicate and is representative of three independent
experiments.

We speculated that the PPARa Gluc sensor would be responsive to
exogenous and endogenous FAs, which might provide a useful means
of detecting intracellular lipolysis. To test the utility of the sensor we
generated a stable BA cell line where the expression of the Gluc FA

sensor could be controlled in doxycycline inducible manner. We ﬁrst
examined whether the luciferase sensor could detect exogenous FAs.
Addition of oleic acid to cells increased the luciferase signal in a doseresponsive manner (Figure 5A). We next examined whether the

Figure 5: The luminescent fatty acid sensor is sensitive to exogenous and endogenous fatty acids. (A) Effect of exogenous fatty acids on the activity of the luminescent fatty
acid sensor in undifferentiated pre-brown adipocytes. Cells were treated with different fatty acid concentrations and the Relative Luminescence Units (RLUs) were determined and
expressed as a fold of bovine serum albumin (BSA). Dose response for CL-316,243 in differentiated BA as determined by measuring free fatty acids (FFA) in the media (B) or RLUs
(C). (D) The Gluc fatty acid sensor is sensitive to inhibition of lipolysis. Differentiated BA were pretreated with the HSL inhibitor (BAY, 5 mM) followed by stimulation with forskolin/
IBMX (Stim) and Relative Luminescence Units (RLUs) were determined. ***p < 0.001 indicates a signiﬁcant effect of HSL inhibition as determine by two-way ANOVA with Bonferroni
post t-test. (E) The Gluc fatty acid sensor detects intracellular fatty acids. Differentiated BA were incubated in the indicated concentrations of bovine serum albumin (BSA) and
treated with isoproterenol (Iso, 1 mM) or ABHD5 ligands (SR-3420, 20 mM). *p < 0.05, ***p < 0.001 indicates a signiﬁcant effect of BSA concentration compared to 1% BSA within
the same treatment group. &&p < 0.01 indicates a signiﬁcant difference between Isoproterenol (Iso) and SR-3420 as determined by two-way ANOVA with Bonferroni post t-test.
Results are from one experiment performed in sextuplet and is representative of three independent experiments.
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luciferase sensor could detect endogenous FAs. BA cells were grown
and differentiated, and the expression of the sensor was induced with
doxycycline treatment for 24e48 h. Stimulation of lipolysis with the
selective b3-adrenoreceptor agonist CL 316,243 (CL) increased
lipolysis over a range of doses as determined by the accumulation of
extracellular FAs, with a EC50 of 8.5 nM (Figure 5B), similar to that
previously reported [29]. The luciferase sensor similarly increased
reporter activity in a dose responsive manner with a calculated EC50 of
3.9 nM, demonstrating the utility of the sensor to detect FAs over a
range of lipolysis activation (Figure 5C). We then examined whether the
sensor was sensitive to inhibition of lipolysis. Treatment of BA cells
with an inhibitor of HSL (BAY), the rate limiting enzyme for the hydrolysis of DAG, resulted in a reduction in luciferase activity when
lipolysis was stimulated, but not under basal conditions (Figure 5D).
We reasoned that the luminescent sensor was reporting the level of
intracellular FAs. To test this, we increased the concentration of
intracellular FAs by systematically lowering extracellular bovine serum
albumin (BSA), the functional acceptor for FA efﬂux [30]. As expected,
stimulation of the b-adrenergic receptor with Iso increased luminescence in cells incubated with 1% BSA and this effect was increased
when the concentration of BSA was lowered to 0.1% and no BSA (0%
BSA) (Figure 5E). When lipolysis was directly stimulated with ABHD5
ligand (SR-3420), which by-passes PKA signaling and negative

feedback regulation on adenylyl-cyclase [30], the effect was lower
compared to Iso in the presence of 1% BSA. However, when the
concentration of BSA was lowered to 0.5%, 0.1% and no BSA, SR3420 had a much greater increase in luciferase activity. Lowering
the concentration of BSA in the medium did not affect luciferase activity under basal conditions (Figure 5E). Overall, these data indicate
that the luciferase sensor detects production of intracellular FA levels.
We also examined whether cells expressing the luciferase reporter
were amenable to culture in multi-well format for more highthroughput analysis. Brown pre-adipocyte cells were cultured
directly in 96-well clear-bottom white luminescent plates. We ﬁrst
tested the sensitivity of the luciferase sensor to detect FAs of different
chain length and saturation. Luminescence increased progressively
with greater FA chain length starting with octanoic acid (C8:0), with
long chain unsaturated FAs (C18:3, C18:1 and C22:6) demonstrating
the greatest increase in luminescence (Figure 6A). Finally, we examined the utility of the FA luminescent sensor to screen for activators
and inhibitors of lipolysis in a 96-well plate. The general b-AR agonist
isoproterenol and chemical ABHD5 ligands SR-4995, SR-4559, and
SR-3420 increased luminescent reporter activity (Figure 6B). The
calculated Z’ score from this assay was 0.627, indicating that the
assay is sufﬁciently reliable for HTS [31]. The effects of isoproterenol
and ABHD5 ligands were partly reduced with HSL inhibition, whereas

Figure 6: The luminescent fatty acid sensor is amenable to high-throughput analysis. (A) Effect of fatty acids of varying chain length and saturation on the luminescent fatty
acid sensor in undifferentiated pre-brown adipocytes. Cells grown in 96-well plate were treated with 400 mM of the indicated fatty acids and the Relative Luminescence Units
(RLUs) were determined. (B and C) The luminescent fatty acid sensor is sensitive to various activators and inhibitors of lipolysis. Brown adipocytes were grown and differentiated in
white 96-well plates and were then treated with activators (Isoproterenol, 1 mM; SR-4995, SR-4559, SR-3420, 20 mM) and inhibitors of lipolysis for 30 min and the RLUs in cells
(B) or mobilized free fatty acids (FFA) in media were determined (C). (D) Correlation between RLUs and FFA from Figure 6 B and D.
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inhibition of ATGL suppressed reporter activity to a greater degree. The
efﬂux of FAs into the extracellular media paralleled the activity of the
luciferase reporter (Figure 6C). The relationship between RLUs and FA
concentration in this assay showed a linear response with a coefﬁcient
of determination of 0.95 (Figure 6D). These data indicate that the
luminescent reporter detects lipolysis induced by different modes of
chemical activation (receptor or ABHD5) and is amenable to highthroughput analysis.
4. DISCUSSION
Our ability to understand the role of FAs in metabolic homeostasis has
been hampered by limitations to image and detect their production in
cells. To address this barrier, we have developed genetically-encoded
sensors that detect FAs by ﬂuorescent and luminescent means. Using
a ﬂuorescent approach, we are able to image the temporal and spatial
dynamics of FA trafﬁcking within cells. Furthermore, a luminescentbased monomeric sensor reports intracellular FA levels and is
amenable to high-throughput analysis. Using these approaches, we have
improved our understanding of how FAs trafﬁc and function within a cell.
Our previous work and that of others suggested a role for lipolytic enzymes in providing signaling molecules to regulate gene transcription
[10,12,13]; however, the temporal and spatial dynamics for this regulation have not been addressed. Using a ﬂuorescence imaging approach,
we took advantage of the ligand-dependent interaction between PPARa
and SRC-1 and demonstrate that FAs produced by LDs can trafﬁc to the
nucleus within minutes of stimulating lipolysis. The exact mechanism by
which FAs trafﬁc from the LDs to the nucleus is currently unknown but
might involve lipid binding proteins, such as fatty acid binding protein
(FABP) 1 and 4, that trafﬁc the ligands [32,33]. ATGL and HSL are the
major lipases in adipocytes; HSL is activated by phosphorylation and
translocation to LDs, whereas ATGL is indirectly activated by the release
of its co-activator ABHD5 from the scaffold protein PLIN1. Indeed, we
found that the kinetics of ATGL and HSL signaling on LDs differed, with
HSL activation required for the initial burst of FA release, and ATGL
showing a steady increase in FA production on LDs. In contrast, both
enzymes had a similar effect on promoting signaling in the nucleus,
consistent with both enzyme regulating gene expression [10,12,34]. We
also examined the effects of direct ABHD5 activation, independent of
PKA stimulation, on lipid signaling. Interestingly, the effect of direct
activation of ABHD5 (SR-3420) on FA production on LDs (Figure 2E) was
similar to that which was seen when lipolysis was driven only by ATGL
(i.e. with HSL inhibition, Figure 2A). However, direct stimulation of
ABHD5 resulted in an increase of FAs signaling to the nucleus similar to
that of receptor activation (Iso), suggesting that direct stimulation of
lipolysis is sufﬁcient to promote signaling to the nucleus. Studies are
currently underway to determine the effects of direct stimulation of
ABHD5 on gene transcription.
The accumulation of EYFP-SRC1 in the nucleus was somewhat surprising since the exogenous PPARa ligand binding domain was targeted
to the LDs, suggesting that SRC-1 was trafﬁcking to the nucleus in a
ligand-dependent manner to bind endogenous nuclear receptors.
Indeed, the binding of the SRC-1 fragment, lacking an activation domain,
suppressed lipolysis-induced transcription of known PPAR target genes.
However, pharmacological inhibition of both ATGL and HSL did not
completely block the accumulation of EYFP-SRC1 within the nucleus
(approximately 80% inhibition), suggesting that PKA-dependent effects
on nuclear import or FA trafﬁcking might exist [35,36].
Quantiﬁcation of FAs typically involves biochemical assays that use
colorimetric or ﬂuorescence-based methods to detect extracellular levels.
In addition, classical assays for determining PPAR transcriptional activity
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require transcription/translation events that can take several hours [27].
We reasoned that we could further take advantage of the liganddependent interaction between PPARa and SRC-1 to develop a monomeric sensor based on split Gluc. This sensor is able to detect synthetic
PPARa ligands and endogenous FAs. Screening of FAs of varying chain
length and saturation demonstrates that long-chain unsaturated FAs are
potent PPARa ligands [27]. In BAs, the sensor accurately reports known
potencies of a b3-AR agonist to stimulate lipolysis and PPARa agonists to
induce gene transcription. Culture of BAs stably expressing the sensor in
white 96-well format to test activators and inhibitors of lipolysis demonstrates that the sensor is amenable to HTS. Targeting lipolysis is of
therapeutic interest, [1,15] and the sensor could be used to screen for
novel pharmacological probes that regulate lipolysis and/or PPARa ligands. Finally, expression of the luciferase sensor in transgenic animals
could be used as an in vivo probe to monitor dynamics of FA production,
uptake, and clearance, thereby improving our understanding of FA
metabolism and their potential lipotoxic effects.
5. CONCLUSIONS
In summary, we have developed genetically-encoded sensors to
determine the temporal and spatial dynamics of FA production, that
typically would not be possible using more conventional approaches.
Given the increased interest in studying FA metabolism and everexpanding obesity epidemic confronting our society, the use of these
sensors will further improve our understanding of FA trafﬁcking and
metabolism.
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